tiprankstipranks
Trending News
More News >
Kuraray Co (JP:3405)
:3405

Kuraray Co (3405) AI Stock Analysis

Compare
0 Followers

Top Page

JP

Kuraray Co

(OTC:3405)

Rating:65Neutral
Price Target:
¥1,948.00
▲(6.27%Upside)
Kuraray Co's overall stock score of 65 reflects a stable financial foundation with consistent revenue growth and strong operating margins, though profitability conversion and valuation metrics suggest room for improvement. Technical analysis indicates mixed momentum, contributing to a moderate stock outlook.

Kuraray Co (3405) vs. iShares MSCI Japan ETF (EWJ)

Kuraray Co Business Overview & Revenue Model

Company DescriptionKuraray Co., Ltd. engages in the production and sale of resins, chemicals, fibers, activated carbon, and high-performance membranes and systems worldwide. The Vinyl Acetate segment manufactures and markets functional resins and films, including PVA, PVB and EVAL. The Isoprene segment engages in the manufacture and marketing of SEPTON thermoplastic elastomer, isoprene-related products, and GENESTAR. The Functional Materials segment manufactures and markets methacrylic resin, medical products, and carbon materials. The Fibers and Textiles segment manufactures and sells synthetic fibers and textiles, CLARINO manmade leather, non-woven fabrics, and other products. The Trading segment mainly processes and sells synthetic fibers and manmade leathers. The company was founded in 1926 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyKuraray Co. makes money primarily through the production and sale of its diverse range of chemical and material products. Its key revenue streams include the sales of specialty chemicals, such as polyvinyl alcohol (PVA) and ethylene vinyl alcohol (EVOH) resins, which are used in various applications ranging from food packaging to automotive and industrial products. The company's fiber and textile segment generates revenue through the sale of high-performance fibers and non-woven fabrics, which have applications in apparel, automotive interiors, and industrial materials. Additionally, Kuraray's medical products division contributes to its earnings by offering dental materials and other healthcare-related products. Strategic partnerships and collaborations with other global companies further enhance its market reach and contribute to its financial performance.

Kuraray Co Financial Statement Overview

Summary
Kuraray Co presents a stable financial position with consistent revenue growth and strong operating margins. The balance sheet reflects moderate leverage and a solid equity foundation, with a low ROE indicating potential inefficiency in using equity capital. Cash flow remains strong, though slight declines in free cash flow growth may require attention.
Income Statement
75
Positive
Kuraray Co has demonstrated a consistent revenue growth trajectory with a 5.88% increase from 2023 to 2024. The gross profit margin for 2024 is 32.35%, indicating strong profitability in its core operations. However, the net profit margin declined to 3.84% in 2024 from the previous year, reflecting increased expenses or potential inefficiencies. The EBIT margin is stable at 10.29%, and the EBITDA margin is 20.60%, showcasing healthy operating performance.
Balance Sheet
70
Positive
The company maintains a solid equity base with an equity ratio of 59.22%, indicating a strong balance sheet. The debt-to-equity ratio is 0.32, suggesting moderate leverage and financial stability. However, the return on equity (ROE) is relatively low at 4.15%, which may indicate underutilization of equity to generate profits.
Cash Flow
65
Positive
Kuraray Co's free cash flow declined slightly by 2.67% from 2023 to 2024, showing some pressure on liquidity. The operating cash flow to net income ratio is 4.36, indicating strong cash generation relative to net income. However, the free cash flow to net income ratio is 2.11, suggesting less efficient translation of profits into free cash flow.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue826.89B780.94B756.38B629.37B541.80B
Gross Profit267.52B239.98B241.66B204.14B165.41B
EBITDA170.34B141.25B144.91B131.26B106.80B
Net Income31.72B42.45B54.31B37.26B2.57B
Balance Sheet
Total Assets1.29T1.25T1.22T1.09T1.05T
Cash, Cash Equivalents and Short-Term Investments121.69B134.62B128.58B155.80B192.24B
Total Debt244.28B282.02B324.40B307.44B341.39B
Total Liabilities509.45B518.33B553.00B511.41B536.11B
Stockholders Equity764.28B714.63B647.09B560.40B499.13B
Cash Flow
Free Cash Flow66.91B68.75B-20.93B8.04B-4.97B
Operating Cash Flow138.29B129.30B51.73B78.22B79.95B
Investing Cash Flow-76.01B-63.15B-68.62B-65.59B-64.03B
Financing Cash Flow-82.50B-64.96B-12.05B-47.45B91.51B

Kuraray Co Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1833.00
Price Trends
50DMA
1730.49
Positive
100DMA
1796.95
Positive
200DMA
1934.37
Negative
Market Momentum
MACD
15.98
Negative
RSI
63.29
Neutral
STOCH
46.63
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3405, the sentiment is Positive. The current price of 1833 is above the 20-day moving average (MA) of 1788.12, above the 50-day MA of 1730.49, and below the 200-day MA of 1934.37, indicating a neutral trend. The MACD of 15.98 indicates Negative momentum. The RSI at 63.29 is Neutral, neither overbought nor oversold. The STOCH value of 46.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3405.

Kuraray Co Peers Comparison

Overall Rating
UnderperformOutperform
Sector (43)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
¥593.65B27.242.92%2.94%5.25%-59.70%
43
Neutral
AU$1.38B-6.10-40.62%4.17%-4.78%-43.21%
$7.32B24.482.49%4.20%
DENSC
€3.50B13.3818.55%4.78%
$4.17B17.196.01%1.78%
$3.90B17.783.96%0.02%
$4.62B12.147.04%0.03%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3405
Kuraray Co
1,833.00
13.74
0.76%
MTLHF
Mitsubishi Chemical Holdings
5.08
-0.39
-7.13%
DE:NSC
Nissan Chemical
25.60
-1.78
-6.50%
SHWDF
Showa Denko KK
23.17
2.13
10.12%
SOMMF
Sumitomo Chemical Co
2.75
0.64
30.33%
TOSCF
Tosoh
14.50
2.12
17.12%

Kuraray Co Corporate Events

Kuraray Co., Ltd. Announces Share Buyback Program
May 14, 2025

Kuraray Co., Ltd. has announced a decision to initiate a share buyback program, as approved by its Board of Directors. This move aligns with the company’s shareholder return policy, aiming to maintain a total return ratio of at least 50% of net income attributable to shareholders, while enhancing capital efficiency and reducing capital costs. The buyback will involve up to 22 million shares, representing approximately 6.79% of total outstanding shares, with a maximum value of ¥30 billion, and will take place between May 15, 2025, and December 15, 2025. The company also plans to cancel the acquired treasury stock, with details to be announced later.

The most recent analyst rating on (JP:3405) stock is a Hold with a Yen2050.00 price target. To see the full list of analyst forecasts on Kuraray Co stock, see the JP:3405 Stock Forecast page.

Kuraray Co. Faces Profitability Challenges Amid Stable Sales in Q1 2025
May 14, 2025

Kuraray Co., Ltd. reported its consolidated financial results for the first quarter of 2025, showing a slight increase in net sales by 1.4% compared to the previous year. However, the company experienced significant declines in operating income, ordinary income, and net income attributable to owners of the parent, with decreases of 35.2%, 36.0%, and 44.4% respectively, indicating challenges in maintaining profitability despite stable sales.

The most recent analyst rating on (JP:3405) stock is a Hold with a Yen2050.00 price target. To see the full list of analyst forecasts on Kuraray Co stock, see the JP:3405 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 25, 2025